|
|
| | Afatinib-d6 Basic information |
| Product Name: | Afatinib-d6 | | Synonyms: | Afatinib-d6;(S,E)-4-(bis(trideuteromethyl)amino)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)but-2-enamide;[2H6]-Afatinib;BIBW 2992 D6;Aaptamine Impurity 6;Afatinib-d | | CAS: | 1313874-96-2 | | MF: | C24H25ClFN5O3 | | MW: | 485.94 | | EINECS: | 604-604-1 | | Product Categories: | | | Mol File: | 1313874-96-2.mol |  |
| | Afatinib-d6 Chemical Properties |
| storage temp. | -20°C Freezer | | solubility | DMSO (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly) | | form | Solid | | color | White to Pale Yellow |
| | Afatinib-d6 Usage And Synthesis |
| Uses | Afatinib-d6 is the d6 labelled analogue of Afatinib (A355300) which is an aminocrotonylamino-substituted quinazoline derivative used for treating cancer and diseases of the respiratory tract, lungs, gastrointestinal tract, bile duct, and gallbladder. |
| | Afatinib-d6 Preparation Products And Raw materials |
|